Updates
** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%
** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay
** White House officials say government will give drugmakers price targets in next 30 days
** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5%
** "While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view," brokerage UBS says
** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.